Mazhar A Kanak1,2, Rauf Shahbazov3, Gumpei Yoshimatsu4, Marlon F Levy5, Michael C Lawrence4, Bashoo Naziruddin6,7. 1. Institute of Biomedical Studies, Baylor University, Waco, TX, USA. mazhar.kanak@vcuhealth.org. 2. Department of Surgery, Transplantation Division, Virginia Commonwealth University, Richmond, VA, USA. mazhar.kanak@vcuhealth.org. 3. Department of Surgery, University of Virginia, Charlottesville, VA, USA. 4. Islet Cell Laboratory, Baylor Research Institute, Dallas, TX, USA. 5. Department of Surgery, Transplantation Division, Virginia Commonwealth University, Richmond, VA, USA. 6. Islet Cell Laboratory, Baylor Research Institute, Dallas, TX, USA. BashooN@BaylorHealth.edu. 7. Baylor Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX, USA. BashooN@BaylorHealth.edu.
Abstract
BACKGROUND: The underlying molecular mechanism that leads to development of chronic pancreatitis remains elusive. The aim of this study is to understand the downstream inflammatory signaling involved in progression of chronic pancreatitis, and to use withaferin A (WA), a small molecule inhibitor of nuclear factor κB (NFκB), to prevent progression of chronic pancreatitis. METHODS: Two different protocols were used to induce pancreatitis in mice: standard and stringent administration of cerulein. The severity of pancreatitis was assessed by means of pancreatic histology and serum amylase levels. Immunohistochemistry and flow-cytometric analysis was performed to visualize immune cell infiltration into the pancreas. Real-time PCR and Western blot were used to analyze the downstream signaling mechanism involved in the development of chronic pancreatitis. RESULTS: The severity of cerulein-induced pancreatitis was reduced significantly by WA, used as either preventive or curative treatment. Immune cell infiltration into the pancreas and acinar cell death were efficiently reduced by WA treatment. Expression of proinflammatory and proapoptotic genes regulated by NFκB activation was increased by cerulein treatment, and WA suppressed these genes significantly. Sustained endoplasmic reticulum stress activation by cerulein administration was reduced. NLRP3 inflammasome activation in cerulein-induced pancreatitis was identified, and this was also potently blocked by WA. The human pancreatitis tissue gene signature correlated with the mouse model. CONCLUSIONS: Our data provide evidence for the role of NFκB in the pathogenesis of chronic pancreatitis, and strongly suggest that WA could be used as a potential therapeutic drug to alleviate some forms of chronic pancreatitis.
BACKGROUND: The underlying molecular mechanism that leads to development of chronic pancreatitis remains elusive. The aim of this study is to understand the downstream inflammatory signaling involved in progression of chronic pancreatitis, and to use withaferin A (WA), a small molecule inhibitor of nuclear factor κB (NFκB), to prevent progression of chronic pancreatitis. METHODS: Two different protocols were used to induce pancreatitis in mice: standard and stringent administration of cerulein. The severity of pancreatitis was assessed by means of pancreatic histology and serum amylase levels. Immunohistochemistry and flow-cytometric analysis was performed to visualize immune cell infiltration into the pancreas. Real-time PCR and Western blot were used to analyze the downstream signaling mechanism involved in the development of chronic pancreatitis. RESULTS: The severity of cerulein-induced pancreatitis was reduced significantly by WA, used as either preventive or curative treatment. Immune cell infiltration into the pancreas and acinar cell death were efficiently reduced by WA treatment. Expression of proinflammatory and proapoptotic genes regulated by NFκB activation was increased by cerulein treatment, and WA suppressed these genes significantly. Sustained endoplasmic reticulum stress activation by cerulein administration was reduced. NLRP3 inflammasome activation in cerulein-induced pancreatitis was identified, and this was also potently blocked by WA. The humanpancreatitis tissue gene signature correlated with the mouse model. CONCLUSIONS: Our data provide evidence for the role of NFκB in the pathogenesis of chronic pancreatitis, and strongly suggest that WA could be used as a potential therapeutic drug to alleviate some forms of chronic pancreatitis.
Entities:
Keywords:
Inflammation; Nuclear factor κB; Pancreatitis; Withaferin A
Authors: David E R Sutherland; David M Radosevich; Melena D Bellin; Bernard J Hering; Gregory J Beilman; Ty B Dunn; Srinath Chinnakotla; Selwyn M Vickers; Barbara Bland; A N Balamurugan; Martin L Freeman; Timothy L Pruett Journal: J Am Coll Surg Date: 2012-03-06 Impact factor: 6.113
Authors: Mohamed I Saad; Teresa Weng; Joanne Lundy; Linden J Gearing; Alison C West; Christopher M Harpur; Mohammad Alanazi; Christopher Hodges; Daniel Croagh; Beena Kumar; Irit Sagi; Stefan Rose-John; Brendan J Jenkins Journal: Proc Natl Acad Sci U S A Date: 2022-10-10 Impact factor: 12.779
Authors: Abdullah Al Mamun; Suzia Aktar Suchi; Md Abdul Aziz; Muhammad Zaeem; Fahad Munir; Yanqing Wu; Jian Xiao Journal: Apoptosis Date: 2022-06-10 Impact factor: 5.561
Authors: Laura R Hoyt; Matthew J Randall; Jennifer L Ather; Daniel P DePuccio; Christopher C Landry; Xi Qian; Yvonne M Janssen-Heininger; Albert van der Vliet; Anne E Dixon; Eyal Amiel; Matthew E Poynter Journal: Redox Biol Date: 2017-04-25 Impact factor: 11.799